Directorate Change

RNS Number : 1207E

Inspiration Healthcare Group PLC

26 February 2020

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Retirement of Chief Financial Officer  

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces that Mike Briant, the Group's Chief Financial Officer, will be retiring from the Board at the end of June 2020. Mike has agreed to continue to work with the Group during a handover period which will end in November 2020. It is intended that Jonathan Ballard, currently Inspiration's Financial Controller, will become the Group's Chief Financial Officer with effect from 1 July 2020. A further announcement concerning Jonathan's proposed appointment to the Inspiration Healthcare Board will be made in due course.

Neil Campbell, Inspiration Healthcare's CEO commented, "On behalf of the entire Board, I would like to thank Mike for his contribution to the Company over the past three and a half years.  I am also pleased that in Jon Ballard we have developed a strong successor to Mike. Jon has been with the business as Group Financial Controller for over three years and, along with the rest of the Board, I look forward to working with him as CFO in the coming years."

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Following the publication of this announcement, this inside information is now considered to be in the public domain.

Enquiries:

Inspiration Healthcare Group plc Neil Campbell, Chief Executive Officer Mike Briant, Chief Financial Officer	Tel: [phone]
Nominated Adviser & Broker Cenkos Securities plc Stephen Keys Mark Connelly	Tel: [phone]
Cadogan PR  Alex Walters [e-mail]	Tel: [phone]

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.  

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products.  This is supported by Technical Support for planned preventative maintenance and emergency assistance.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

 

END

 

 

BOADBGDDGBDDGGU